Gemma Gatta

31.6k citations

205 papers · 11.9k indexed · 3 hit papers · h-index 59

Impact in

Oncology top 0.2%
- Colorectal Cancer Screening and Detection
- Global Cancer Incidence and Screening
Otorhinolaryngology top 0.5%

Papers in

Oncology 108
- Global Cancer Incidence and Screening 54
- Colorectal Cancer Screening and Detection 40
- Cancer Risks and Factors 17
Otorhinolaryngology 16

Co-authors: Riccardo Capocaccia Franco Berrino Andrea Micheli Milena Sant Laura Ciccolallo Michel P. Coleman Lisa Licitra Charles Stiller
Journals: European Journal of Cancer (33 papers)Critical Reviews in Oncology/Hematology (32 papers)Annals of Oncology (9 papers)Frontiers in Oncology (7 papers)Cancer Epidemiology (7 papers)
Partner nations: Italy United Kingdom Netherlands

In The Last Decade

Gemma Gatta

197 papers receiving 11.5k citations

Hit Papers

align trajectories log scale

Rare cancers are not so rare: The rare cancer burden in Europe 2011 · 500 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 European Journal of Cancer
2007 The Lancet Oncology
2003 Annals of Oncology

Peers

Countries citing papers authored by Gemma Gatta

Since Specialization

Citations

This map shows the geographic impact of Gemma Gatta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma Gatta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma Gatta more than expected).

Fields of papers citing papers by Gemma Gatta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gemma Gatta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma Gatta. The network helps show where Gemma Gatta may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gemma Gatta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gemma Gatta Line = papers co-authored together Gemma Gatta links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Challenges of cancer registration and epidemiology in Italy Cancer Epidemiology ·Fabrizio Stracci, Margherita Ferrante, Adele Caldarella, Silvia Francisci, Mario Fusco, Gemma Gatta, Diego Serraino, William Mantovani, Walter Mazzucco	2025	2
2	Incidence rates and trends of paediatric cancer in Italy, 2008–2017 Cancer Epidemiology ·Joanna Kranz, Gemma Gatta, Katherine Briggette, Sabrina Fabiano, Francesco Cuccaro, H. Thomas Cunningham, Andrea Tittarelli, T. Scuderi, Rosalba Amodio, Walter Mazzucco, Fabrizio Stracci, Ri-BoHUANG, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2025	1
3	Childhood and adolescents’ cancer survival: Progress made and priorities for improvement. An Italian population-based study Cancer Epidemiology ·Fazira Latib, Rosalba Amodio, Sabrina Fabiano, Gemma Gatta, Milena Maule, H. Thomas Cunningham, Katherine Briggette, د شيخة بداح الحجرف, Andrea Tittarelli, Walter Mazzucco, Fabrizio Stracci, Rosalia Ragusa, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2025	0
4	The impact of cancer survivors’ extra risk of noncancer mortality on net survival estimation American Journal of Epidemiology ·Laura Botta, Riccardo Capocaccia, Alice Bernasconi, Silvia Rossi, Jaume Galcerán, Luigino Dal Maso, Côme Lepage, Florence Molinié, Anne‐Marie Bouvier, Rafael Marcos‐Gragera, Claudia Vener, Marcela Guevara, Deirdre M. Murray, Rosalia Ragusa, Gemma Gatta, Valérie Jooste, Mélanie Gachet, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2025	0
5	International benchmarking of stage at diagnosis for six childhood solid tumours (the BENCHISTA project): a population-based, retrospective cohort study The Lancet Child & Adolescent Health ·Laura Botta, J. Montgomery, Olabode Togunwa, Adela Cañete, Emmanuel Désandes, Lisa Lyngsie Hjalgrim, Zsuzsanna Jakab, Charles Stiller, Bernward Zeller, Gemma Gatta, Kathy Pritchard‐Jones, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2025	5
6	Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers European Journal of Cancer ·Laura Botta, Riccardo Capocaccia, Alice Bernasconi, Silvia Rossi, Jaume Galcerán, Luigino Dal Maso, Côme Lepage, Florence Molinié, Anne‐Marie Bouvier, Rafael Marcos‐Gragera, Claudia Vener, Marcela Guevara, Deirdre M. Murray, Rosalia Ragusa, Gemma Gatta, Valérie Jooste	2024	4
7	Prediction of Risk of Metastatic Recurrence for Female Breast Cancer Patients in the Presence of Competing Causes of Death Cancer Epidemiology Biomarkers & Prevention ·Angela B. Mariotto, Laura Botta, Alice Bernasconi, Zhaohui Zou, Gemma Gatta, Riccardo Capocaccia	2023	2
8	Current management and future challenges in salivary glands cancer Frontiers in Oncology ·Laura D. Locati, Renata Ferrarotto, Lisa Licitra, Marco Benazzo, Lorenzo Preda, Davide Farina, Gemma Gatta, Davide Lombardi, Piero Nicolai, Vincent Vander Poorten, Melvin L.K. Chua, Barbara Vischioni, Giuseppe Sanguineti, Patrizia Morbini, Isabel Fonseca, Davide Sozzi, Anna Merlotti, Ester Orlandi	2023	11
9	Cancer treatment data available in European cancer registries: Where are we and where are we going? Frontiers in Oncology ·Francesco Giusti, Carmen Martos, Annalisa Trama, Manola Bettio, Arantza Sanvisens, Riccardo A. Audisio, Volker Arndt, Silvia Francisci, Carine Dochez, Josepa Ribes, 利英佐賀, Anna Gavin, Gemma Gatta, Rafael Marcos‐Gragera, Yolande Lievens, Claudia Allemani, Roberta De Angelis, Otto Visser, Liesbet Van Eycken, (unknown)	2023	15
10	Variation of Cancer Incidence between and within GRELL Countries International Journal of Environmental Research and Public Health ·Paolo Contiero, Giovanna Tagliabue, Gemma Gatta, Jaume Galcerán, Jean‐Luc Bulliard, Martina Bertoldi, Alessandra Scaburri, Emanuele Crocetti, (unknown)	2021	2
11	Where Are Adolescents with Soft Tissue Sarcomas Treated? An Italian Nationwide Study on Referrals Based on Hospital Discharge Records Journal of Adolescent and Young Adult Oncology ·Andrea Ferrari, Alice Bernasconi, Giovanna Sironi, Luca Bergamaschi, Laura Botta, Stefano Chiaravalli, Michela Casanova, Gianni Bisogno, Giuseppe Maria Milano, Maurizio Mascarin, Assunta Tornesello, Paola Quarello, Maura Massimino, Gemma Gatta, Annalisa Trama	2019	4
12	Bayesian estimates of the incidence of rare cancers in Europe Cancer Epidemiology ·Laura Botta, Riccardo Capocaccia, Annalisa Trama, C. Herrmann, Diego Salmerón, Roberta De Angelis, Sandra Mallone, Ettore Bidoli, Rafael Marcos‐Gragera, Stefanie Andrea Goetz, Gemma Gatta, Ramón Clèries	2018	7
13	Thymoma and thymic carcinomas Critical Reviews in Oncology/Hematology ·Marta Scorsetti, Francesco Leo, Annalisa Trama, Rolando Maria D’Angelillo, Danila Serpico, Marianna Macerelli, Paolo Andrea Zucali, Gemma Gatta, Marina Chiara Garassino	2016	200
14	Trend analysis of gastric cancer and colorectal cancer mortality in Iran, 1995-2003 Iranian Journal of Cancer Prevention ·Mohamad Amin Pourhoseingholi, Soghrat Faghihzadeh, Ebrahim Hajizadeh, Gemma Gatta, Mohammad Reza Zali, Alireza Abadi	2011	11
15	Rare cancers are not so rare: The rare cancer burden in Europe European Journal of Cancer ·Gemma Gatta, Jan Maarten van der Zwan, Paolo G. Casali, Sabine Siesling, Angelo Paolo Dei Tos, Ian Kunkler, R. Otter, Lisa Licitra, Sandra Mallone, Andrea Tavilla, Annalisa Trama, Riccardo Capocaccia Hit paper breakdown →	2011	500
16	Cancer survival in European adolescents and young adults European Journal of Cancer ·Gemma Gatta, Riccardo Capocaccia, Roberta De Angelis, Charles Stiller, J.W.W. Coebergh	2003	67
17	EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century Annals of Oncology ·Michel P. Coleman, Gemma Gatta, A. Verdecchia, Jacques Estève, Milena Sant, Hans H. Storm, Claudia Allemani, Laura Ciccolallo, Mariano Santaquilani, Franco Berrino	2003	341
18	Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978 European Journal of Cancer ·Gemma Gatta, Roberto Luksch, Michel P. Coleman, Isabella Corazziari	2001	15
19	Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study Gut ·Gemma Gatta, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2000	190
20	Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours European Journal of Cancer ·Franco Berrino, Gemma Gatta	1998	86

About Gemma Gatta

Gemma Gatta is a scholar working on Oncology, Otorhinolaryngology, Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Genetics, having authored 205 papers that have together received 11.9k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (54 papers), Colorectal Cancer Screening and Detection (40 papers), Childhood Cancer Survivors' Quality of Life (26 papers), Multiple and Secondary Primary Cancers (26 papers), Acute Lymphoblastic Leukemia research (26 papers), Genetic factors in colorectal cancer (25 papers), Cancer Risks and Factors (17 papers) and Glioma Diagnosis and Treatment (13 papers). The work is most often cited by research in Oncology (5.3k citations), Otorhinolaryngology (538 citations), Cancer Research (1.4k citations), Pathology and Forensic Medicine (1.5k citations) and Pulmonary and Respiratory Medicine (2.6k citations). Gemma Gatta has collaborated with scholars based in Italy, United Kingdom and Netherlands. Frequent co-authors include Riccardo Capocaccia, Franco Berrino, Andrea Micheli, Milena Sant, Laura Ciccolallo, Michel P. Coleman, Lisa Licitra, Charles Stiller, Jean Faivre and Ian Kunkler. Their work appears in journals such as European Journal of Cancer, Critical Reviews in Oncology/Hematology, Annals of Oncology, Frontiers in Oncology and Cancer Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact